AGP has added the beta-adrenoceptors blocker Glaten®

Nov 12, 2012 African Global Pharma Corp.(AGP) has added the beta-adrenoceptors blocker Glaten® to its over-the-counter line of pharmaceuticals. It is being produced in African Global Pharma’s Ghana manufacturing facility. The medication contains Atenolol and is used for the treatment of hypertension, angina and myocardial infarction. Glaten® is being made available in 50mg tablets and joins four other over-the-counter pharmaceuticals being produced and distributed by AGP. Glibenclamide (anti-diabetic), Globaterm® and Gloderp® (anti-malarials) and the analgesic Paracetamol are currently being produced and distributed by African Global Pharma in Ghana.

 

About African Global Pharma, Ghana

African Global Pharma (Ghana) Limited is an affiliated company of African Global Pharma Corp. of Canada with business partnership with the Catholic Diocese of Sunyani to distribute all our manufactured drugs to the Catholic Mission Hospitals. African Global Pharma’s production facility in Sunyani, Ghana was fully rehabilitated and built by African Global Pharma Corp, Canada. The plant and its operations are headquartered in Sunyani at the Diocesan Bldg.

 

 

http://www.prlog.org/12018419-african-global-pharma-corp-receives-approval-to-produce-anti-diabetic-tablet-glibenclamide.html

 

http://www.prlog.org/12016173-african-global-pharma-gh-now-producing-first-line-of-over-the-counter-analgesic-paracetamol.html